Survival in adult acute lymphoblastic leukaemia ( ALL ): A report from the Swedish ALL registry

Emma Bergfelt Lennmyr,Karin Karlsson,Lucia Ahlberg,Hege Garelius,Erik Hulegårdh,Antonio Santamaria Izarra,Joel Joelsson,Piotr Kozlowski,Andreea Moicean,Beata Tomaszewska-Toporska,Anna Lübking,Helene Hallböök

Survival in adult acute lymphoblastic leukaemia ( ALL ): A report from the Swedish ALL registry

2019

Emma Bergfelt Lennmyr
Karin Karlsson
Lucia Ahlberg
Hege Garelius
Erik Hulegårdh
Antonio Santamaria Izarra
Joel Joelsson
Piotr Kozlowski
Andreea Moicean
Beata Tomaszewska-Toporska
Anna Lübking
Helene Hallböök

Objectives As new, effective therapies emerge for acute lymphoblastic leukaemia (ALL), the results of clinical trials need to relate to standard of care.

Keywords:

Immunology
Lymphoblastic leukaemia
Diabetes mellitus
Pediatrics
Medicine
Lower risk
Population
Clinical trial
Internal medicine
Disease
Cohort
Standardized mortality ratio

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations